How a one-minute jolt from the SetPoint implant offers new hope for autoimmune disease patients

The US Food and Drug Administration has approved a new medical device for rheumatoid arthritis. The SetPoint System is an implant that stimulates the vagus nerve. It reduces inflammation by re-educating the immune system. Clinical trials show promising results with reduced joint pain and swelling. Experts express cautious optimism about this drug-free approach.